Abstract:Abstract Purpose: We aimed to evaluate 68Ga-DOTA-FAPI-04 PET/CT versus 18F-FDG PET/CT in the application of fibroblastic tumors.Methods: Twenty patients with 6 subtypes of fibroblastic tumors prospectively underwent 18F-FDG and 68Ga-DOTA-FAPI-04 PET/CT examinations to evaluate the lesions. PET/CT findings were confirmed by surgical pathology, puncture biopsy, or imaging follow-up. Two independent sample t tests were used to compare the uptake of 18F-FDG vs. 68Ga-DOTA-FAPI-04 in primary, recurrent and metastatic lesions. One-way ANOVA was used to compare the uptake of 18F-FDG or 68Ga-DOTA-FAPI-04 among primary, recurrent, and metastatic lesions. The uptake of 68Ga-DOTA-FAPI-04 vs. 18F-FDG in different histopathological lesions was compared by two independent sample t tests.Results: Twenty patients were finally confirmed to have 38 lesions. Although there was no significant difference in the detection of all lesions between 68Ga-DOTA-FAPI-04 and 18F-FDG PET/CT (38 vs. 36, p=0.493), the uptake of 68Ga-DOTA-FAPI-04 in lesions was significantly higher than that of 18F-FDG (p<0.001), including primary (p<0.001), recurrent (p=0.018) and metastatic (p<0.001) lesions. The SUVmax of 68Ga-DOTA-FAPI-04 in primary and recurrent lesions was higher than that in metastasis (p=0.034 and p=0.015, respectively). The SUVmax of 68Ga-DOTA-FAPI-04 in primary and recurrent malignant lesions was significantly higher than that of the intermediate (p<0.001). The SUVmax of 18F-FDG in solitary fibrous tumors (SFTs) was significantly lower than that in non-SFT lesions (p=0.029). The SUVmax of 68Ga-DOTA-FAPI-04 in one case of recurrent SFT with 5 lesions was significantly lower after treatment than before treatment (p =0.016).Conclusion: 68Ga-DOTA-FAPI-04 outperformed 18F-FDG PET/CT in displaying the primary, recurrent and metastatic lesions of fibroblastic tumors. 68Ga-DOTA-FAPI-04 PET/CT may also show potential value for judging the nature and monitoring the therapeutic response of tumors.

Comparison of 18F-FAPI and 18F-FDG PET/CT in a Patient With Fibrous Dysplasia

18F-FDG PET Findings of a Case of Polyostotic Fibrous Dysplasia

68Ga-FAPI-04 PET/CT Imaging for Fibrous Dysplasia of the Bone

Head‑to‑head assessment of 68Ga-DOTA-FAPI-04 PET/CT vs 18 F-FDG PET/CT in fibroblastic tumors

Head‐to‐head assessment of [68Ga]Ga-DOTA-FAPI-04 PET/CT vs [18F]FDG PET/CT in fibroblastic tumors

Noninvasive imaging of FAP expression using positron emission tomography: A comparative evaluation of a [18F]-labeled glycopeptide-containing FAPI with [18F]FAPI-42

Evaluating the diagnostic value of 18F-FAPI-04 PET/CT in various malignant tumors: a head-to-head comparison with 18F-FDG PET/CT

18 F-FAPI-42 Versus 18 F-FDG PET/MRI in a Case of Primary Peripheral T-Cell Lymphoma of the Skeletal Muscles

The Manifestation of a Patient With Myelofibrosis in 68Ga-DOTA-FAPI-04 PET/CT Mimicking "Super Bone Imaging"

Comparison of 68Ga-DOTA-FAPI-04 and 18F-FDG PET/CT in Patients With SAPHO Syndrome

Head to head comparison of 68Ga-DOTA-FAPI-04 vs 18F-FDG PET/CT in the evaluation of primary extrapulmonary tumors in the chest

Superiority of 18F-FAPI-42 PET/CT in the detection of primary tumor and management of appendiceal neoplasm to 18F-FDG PET/CT and CE-CT

The 68Ga-DOTA-FAPI-04 PET/CT for the differential diagnosis of solitary fibroma of pleura from other chest disease with low uptake of 18F-FDG

Ga-68-Dota-Fapi-04 Pet/Ct In Erdheim-Chester Disease

The Ga-68-DOTA-FAPI-04 PET/CT for the differential diagnosis of solitary fibroma of pleura from other chest disease with low uptake of F-18-FDG

The Value of Bone Scintigraphy in Diagnosis of Fibrous Dysplasia of Bone

18F-FAPI for Imaging Metastatic Perivascular Epithelioid Cell Neoplasm

The diagnostic value of [18F]FAPI-42 PET/CT for pulmonary artery masses: comparison with [18F]FDG PET/CT

Superior Identification of Metastatic Lesions by 68 Ga-FAPI-46 PET/CT Than 18 F-FDG PET/CT in Hepatic Solitary Fibrous Tumor

Superior Identification of Metastatic Lesions by 68Ga-FAPI-46 PET/CT Than 18F-FDG PET/CT in Hepatic Solitary Fibrous Tumor

68Ga-DOTA-FAPI-04 PET/CT in Erdheim-Chester Disease